Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01212523Phase 4Completed
Phase 4, randomised, open-label trial in pulmonary hypertension (PH) comparing Isoflurane with Propofol (2 arms). Primary endpoint: Pulmonary Vascular Resistance at 2 hours. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01212523.